Vir Biotechnology
VIR
NASDAQ
IPO2019
about VIR
Vir Biotechnology is a company focused on developing innovative medicines and technologies to treat and prevent viral diseases, including hepatitis B and COVID-19.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.54 | $7.79 | $7.26 | $1.1B | 9.88M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.17 | n/a | 7212.79 | -72267.92% | -67975.42% | 0.80% |